Tus%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd

## Overview Tus%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd is a brand name for the combination of guaifenesin and dextromethorphan. Guaifenesin is an expectorant that helps loosen mucus in the airways, and dextromethorphan is a cough suppressant. ## Primary Indications * Relief of cough associated with the common cold. * Temporary relief of nasal congestion. * Helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive. ## Adult Dosing The dosing for Tus%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd will depend on the specific formulation (e.g., liquid, tablet). Refer to product labeling for exact dosing. Generally, it is administered every 4 to 6 hours as needed. Do not exceed 6 doses in 24 hours. ## Pediatric Dosing Safety and efficacy in pediatric patients below 12 years of age have not been established for many guaifenesin/dextromethorphan products. Specific pediatric dosing depends on the product and age group; consult product labeling or a pediatrician. ## Dose Adjustments No specific dose adjustments are typically required for renal or hepatic impairment, but caution should be used, and the lowest effective dose should be considered. ## Contraindications * Hypersensitivity to guaifenesin or dextromethorphan. * Use within 14 days of a monoamine oxidase inhibitor (MAOI) due to dextromethorphan. * Concurrent use with certain selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) may increase the risk of serotonin syndrome. ## Adverse Effects Common adverse effects include dizziness, drowsiness, nausea, and vomiting. Less common effects can include headache, rash, and gastrointestinal upset. ## Key Drug Interactions * **Monoamine Oxidase Inhibitors (MAOIs):** Increased risk of serotonin syndrome or hypertensive crisis with dextromethorphan. * **SSRIs and SNRIs:** Increased risk of serotonin syndrome with dextromethorphan. * **CNS Depressants:** Additive sedative effects with alcohol, benzodiazepines, opioids, and sedating antihistamines. * **CYP2D6 Inhibitors:** May increase dextromethorphan levels, leading to increased toxicity. ## Monitoring * Monitor for effectiveness in reducing cough and loosening mucus. * Monitor for adverse effects, particularly drowsiness and dizziness. * Assess for signs of serotonin syndrome (agitation, hallucinations, rapid heart rate, fever, sweating, muscle rigidity) if taken with serotonergic agents. ## Clinical Pearls * This combination product targets both cough suppression and mucus expectoration. * Ensure adequate hydration when taking guaifenesin to help loosen mucus. * Avoid alcohol and other CNS depressants while taking this medication due to increased drowsiness. * If cough persists for more than 7 days, recurs, or is accompanied by fever, rash, or persistent headache, discontinue use and consult a physician. --- *Disclaimer: This information is intended for healthcare professionals. Always verify the most current prescribing information and consult relevant resources before making clinical decisions.*